Press release
Prescription Stimulants Market 2018-2028 by Key Prominent Players - Novartis AG, Janssen Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Ltd., Independence Pharmaceuticals, Arbor Pharmaceuticals Inc., Sun Pharmace
Prescription stimulants are administered to treat disorders in which activity levels, attention, and moods are affected, which is most significantly in conditions of ADHD (Attention deficit hyperactivity disorder). The major use of prescription stimulants is to increase the activity of the CNS (Central Nervous System), majorly by acting on the neurotransmitters norepinephrine and dopamine. Illegal usage of prescription stimulants often stems because of the willingness to cognitive enhancements and is popular in business and academic professionals, majorly athletes, students and performers. According to the various surveys conducted over ten years, prescription stimulants abuse has been consistently on the rise, for instance, approximately 7 million Americans reported the non-medical use of prescription stimulants in 2009. This statistics exceeds the use of cocaine, heroin, hallucinogens, and inhalants combined.
Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3414
Increasing awareness on prescription stimulants for the treatment of various mental disorders like attention deficit hyperactivity disorders etc. is expected to boost demand for prescription stimulants over the forecast period. Increasing incidence of various disorders like narcolepsy, depression, ADHD, and various acquired brain injuries is also expected to fuel demand for prescription stimulants over the forecast period. Growing popularity of prescription stimulants and increasing funding for researches based on the safe use of these prescription stimulants is also projected to propel market demand for prescription stimulants. However, drug abuse related to prescription stimulants might hinder market growth over the forecast period. The potential for prescription stimulants abuse is increasing owing it to the exponential increase in the availability of these drugs. Also, while prescription stimulants boost mental performance and concentration, it is also linked to causing adverse physiological reactions in the body. Constant abuse can lead to poor health over time. This is anticipated to obstruct market growth for prescription stimulants over the forecast period.
Global Prescription Stimulants market has witnessed growth due to increasing availability of these drugs for mental care purposes, often abused for mental pleasure. Prescription stimulants come in capsules or tablets. While the abuse, prescription stimulants are injected in liquid form, swallowed, or snorted. Several researches based on prescription stimulants states that the repeated high doses of prescription stimulants over a short period can cause feelings of paranoia and hostility. Prescription stimulants are used to increase levels of dopamine in the brain. Dopamine is a neurotransmitter which is associated with movement, pleasure, and attention. According to a survey conducted by various drug abuse associations, Prescription stimulants such as Ritalin and Adderall are two of the most frequently abused prescription stimulants by high school seniors, with 6.5% reporting non-medical use of Adderall in 2010, in the United States. Prescription stimulants when used legally for treatment of mental disorders, could help patients tremendously. The medical professionals are advised to monitor all possible negative and possible outcomes when they prescribe these stimulants for treatment purposes.
Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=3414
Geographically, global Prescription Stimulants market is segmented into regions viz. North America, Latin America, Asia Pacific and the Middle East & Africa, Western Europe, Eastern Europe. North America’s prescription stimulants market is expanding because of high rate of FDA approved drugs and increasing availability of these prescription stimulants. The market is expected to remain dominant over the period of forecast due to increase in healthcare expenditure and increasing incidence of ADHD, depression and narcolepsy in the region. Europe’s prescription stimulants market is also expected to grow significantly due to high number of manufacturer presence for prescription stimulants and huge teenage population abusing prescription stimulants for mental pleasure. Asia-Pacific prescription stimulants market is anticipated to grow at a decent rate due to growing awareness and availability of prescription stimulants in the region.
Some of the market participants in the Global Prescription Stimulants market identified across the value chain include: Novartis AG, Janssen Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Ltd., Independence Pharmaceuticals, Arbor Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., UCB, Inc., Tris Pharma, Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, NEOS Therapeutics, Inc., Purdue Pharma L.P., Eli Lilly and Company, and H. Lundbeck A/S.
You can Buy This Report from Here @ https://www.factmr.com/checkout/3414/S
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Read Industrial News : http://insiderstribune.com/
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prescription Stimulants Market 2018-2028 by Key Prominent Players - Novartis AG, Janssen Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Ltd., Independence Pharmaceuticals, Arbor Pharmaceuticals Inc., Sun Pharmace here
News-ID: 1790354 • Views: …
More Releases from Fact.MR
Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
According to Fact.MR, a trusted provider of market research and competitive intelligence, the global Luxury Eyewear Market was valued at US$ 40 billion in 2023. Projections suggest that by the conclusion of 2033, this market is anticipated to escalate to US$ 56 billion. Forecasts indicate a steady Compound Annual Growth Rate (CAGR) of 3.4% in the global demand for luxury eyewear from 2023 to 2033.
The surge in luxury eyewear sales…
Camping Equipment sales are expected to reach US$ 33.17 billion By 2032
The global camping equipment market is projected to achieve a substantial value of US$ 33.17 billion by the year 2032, exhibiting a commendable Compound Annual Growth Rate (CAGR) of 7.3% from 2022 to 2032. A surge in expenditure on outdoor recreational activities is poised to ignite significant growth within the camping equipment market.
According to insights from Fact.MR, the global camping equipment market is forecasted to reach a valuation of US$…
Microbial Algae Products is forecasted to expand at a CAGR of 6.1% from 2024 to …
The global microbial algae product market is set to expand at a compound annual growth rate (CAGR) of 6.1%, as outlined in the latest industry research report by Fact.MR. By the end of 2034, the market is anticipated to surge from US$ 3.43 billion in 2024 to US$ 6.2 billion.
Recent years have witnessed a notable surge in demand for microbial algae products due to their rich nutritional profile, comprising minerals,…
Life Insurance Policy Administration System market is projected to rise at a CAG …
As per a recent study conducted by Fact.MR, a reputable market research and competitive intelligence firm, the global Life Insurance Policy Administration System Market is poised to grow at a robust Compound Annual Growth Rate (CAGR) of 12.2% until the year 2034. The market is forecasted to achieve a valuation of US$ 6,689.2 million by the end of 2024, with further projections indicating a potential surge to US$ 21,115.2 million…
More Releases for Prescription
Prescription Spectacles Market Growth Trajectory 2022-28
According to Precision Business Insights (PBI), the latest report, the Prescription Spectacles market is expected to be valued at USD 43,584.1 million in 2022, growing at a 3.1% CAGR from 2022 to 2028. Growing rely on electronic devices like mobile, laptops, computers for day-to-day work and entertainment and too much involvement at glaring at the screen even in the night time coming with the side effect of ocular problems. As…
SRI Format Romania e-Prescription: The first e-prescription that can be used thr …
The transeuropean online doctor service www.private-GP.org has become the first EU-wide user of the "SRI Format Romania" for e-prescriptions. Convenient and secure for patients, simple and user-friendly for pharmacies.
"This means that privateGP doctors can make things even easier for their patients and also provide better security for pharmacies," emphasizes Dr. Martin Kramer, who is responsible for introducing the new technology at privateGP. "The combination of safety and functionality is impressive…
Electronic Prescription Software Market Insights
The Global Electronic Prescription Software Market covers unequivocal information regarding the development rate, request estimates, motorists, limitations, future-grounded demand, and profit during the cast period. The Global Electronic Prescription Software Market consists of data accumulated from multitudinous primary and secondary sources. This information has been vindicated and validated by the assiduity judges, therefore furnishing significant perceptivity to the experimenters, judges, directors, and other assiduity professionals. This document further helps in…
Prescription/Rx Sunglass Market 2022 | Detailed Report
The Prescription/Rx Sunglass research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,…
Latest Medicare Prescription Drug Plan Data Reported
Some 48 million Americans are enrolled in Medicare prescription drug plans according to the latest data reported by the American Association for Medicare Supplement Insurance.
“Prescription drug plan coverage is one of the most important benefits valued by seniors on Medicare,” states Jesse Slome, director of the Medicare advocacy organization. “Individuals have enormous choice today and selecting the right prescription drug plan coverage can be a significant money saver.”
According to…
The Best Prescription Safety Sunglasses – New Features
08/10/2021 – Middlesex, NJ: Prescription safety sunglasses can be an immensely valuable accessory in your work life. They can protect you from all kinds of elements when you’re on the job, including dust, dirt, sand, and other foreign materials. Not only that, but prescription safety sunglasses can be extremely stylish. When you are working in challenging conditions, you want your eyewear to be both functional and aesthetically pleasing.
However, if you…
